![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: APBB2 |
Gene summary for APBB2 |
![]() |
Gene information | Species | Human | Gene symbol | APBB2 | Gene ID | 323 |
Gene name | amyloid beta precursor protein binding family B member 2 | |
Gene Alias | FE65L | |
Cytomap | 4p14-p13 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | B4DJ88 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
323 | APBB2 | PTC01 | Human | Thyroid | PTC | 6.55e-11 | -1.36e-01 | 0.1899 |
323 | APBB2 | PTC03 | Human | Thyroid | PTC | 3.24e-11 | 1.38e-01 | 0.1784 |
323 | APBB2 | PTC04 | Human | Thyroid | PTC | 6.23e-13 | 6.94e-02 | 0.1927 |
323 | APBB2 | PTC05 | Human | Thyroid | PTC | 1.15e-13 | 2.55e-01 | 0.2065 |
323 | APBB2 | PTC06 | Human | Thyroid | PTC | 1.22e-23 | 2.23e-01 | 0.2057 |
323 | APBB2 | PTC07 | Human | Thyroid | PTC | 1.01e-26 | 1.76e-01 | 0.2044 |
323 | APBB2 | ATC09 | Human | Thyroid | ATC | 3.83e-05 | 3.68e-03 | 0.2871 |
323 | APBB2 | ATC11 | Human | Thyroid | ATC | 4.51e-02 | 5.36e-01 | 0.3386 |
323 | APBB2 | ATC12 | Human | Thyroid | ATC | 6.12e-21 | -1.28e-02 | 0.34 |
323 | APBB2 | ATC13 | Human | Thyroid | ATC | 2.03e-27 | 4.23e-01 | 0.34 |
323 | APBB2 | ATC1 | Human | Thyroid | ATC | 2.98e-03 | 1.56e-03 | 0.2878 |
323 | APBB2 | ATC2 | Human | Thyroid | ATC | 1.43e-10 | 1.14e+00 | 0.34 |
323 | APBB2 | ATC3 | Human | Thyroid | ATC | 5.94e-05 | 6.16e-01 | 0.338 |
323 | APBB2 | ATC4 | Human | Thyroid | ATC | 2.04e-26 | 5.20e-02 | 0.34 |
323 | APBB2 | ATC5 | Human | Thyroid | ATC | 5.04e-34 | 4.70e-01 | 0.34 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0060249 | Colorectum | AD | anatomical structure homeostasis | 94/3918 | 314/18723 | 9.37e-05 | 1.42e-03 | 94 |
GO:0001894 | Colorectum | AD | tissue homeostasis | 81/3918 | 268/18723 | 1.96e-04 | 2.62e-03 | 81 |
GO:0050808 | Colorectum | AD | synapse organization | 112/3918 | 426/18723 | 4.25e-03 | 2.92e-02 | 112 |
GO:00018941 | Colorectum | SER | tissue homeostasis | 66/2897 | 268/18723 | 5.87e-05 | 1.37e-03 | 66 |
GO:00602491 | Colorectum | SER | anatomical structure homeostasis | 74/2897 | 314/18723 | 1.01e-04 | 2.13e-03 | 74 |
GO:0003012 | Colorectum | SER | muscle system process | 92/2897 | 452/18723 | 2.98e-03 | 2.63e-02 | 92 |
GO:00508081 | Colorectum | SER | synapse organization | 85/2897 | 426/18723 | 7.17e-03 | 4.99e-02 | 85 |
GO:00602492 | Colorectum | MSS | anatomical structure homeostasis | 84/3467 | 314/18723 | 1.87e-04 | 2.64e-03 | 84 |
GO:00018942 | Colorectum | MSS | tissue homeostasis | 72/3467 | 268/18723 | 4.53e-04 | 5.40e-03 | 72 |
GO:00508082 | Colorectum | MSS | synapse organization | 101/3467 | 426/18723 | 3.96e-03 | 2.89e-02 | 101 |
GO:00030121 | Colorectum | MSS | muscle system process | 105/3467 | 452/18723 | 6.39e-03 | 4.26e-02 | 105 |
GO:00602493 | Colorectum | MSI-H | anatomical structure homeostasis | 38/1319 | 314/18723 | 7.73e-04 | 1.44e-02 | 38 |
GO:00018943 | Colorectum | MSI-H | tissue homeostasis | 33/1319 | 268/18723 | 1.24e-03 | 2.00e-02 | 33 |
GO:00508083 | Colorectum | FAP | synapse organization | 91/2622 | 426/18723 | 1.90e-05 | 4.74e-04 | 91 |
GO:00018944 | Colorectum | FAP | tissue homeostasis | 61/2622 | 268/18723 | 6.71e-05 | 1.28e-03 | 61 |
GO:00602494 | Colorectum | FAP | anatomical structure homeostasis | 69/2622 | 314/18723 | 7.51e-05 | 1.37e-03 | 69 |
GO:00030122 | Colorectum | FAP | muscle system process | 89/2622 | 452/18723 | 4.63e-04 | 5.39e-03 | 89 |
GO:00602495 | Colorectum | CRC | anatomical structure homeostasis | 57/2078 | 314/18723 | 1.24e-04 | 2.41e-03 | 57 |
GO:00508084 | Colorectum | CRC | synapse organization | 71/2078 | 426/18723 | 3.02e-04 | 4.76e-03 | 71 |
GO:00030123 | Colorectum | CRC | muscle system process | 74/2078 | 452/18723 | 3.92e-04 | 5.80e-03 | 74 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
APBB2 | SNV | Missense_Mutation | c.797C>T | p.Ser266Phe | p.S266F | Q92870 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-BH-A0AV-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR | |
APBB2 | SNV | Missense_Mutation | rs374033109 | c.1478C>T | p.Ser493Leu | p.S493L | Q92870 | protein_coding | deleterious(0.01) | benign(0.181) | TCGA-BH-A18G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
APBB2 | SNV | Missense_Mutation | novel | c.1210G>A | p.Asp404Asn | p.D404N | Q92870 | protein_coding | tolerated(0.16) | benign(0.367) | TCGA-BH-A28O-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | cytoxan | CR |
APBB2 | insertion | In_Frame_Ins | novel | c.539_540insTGTTAAGTA | p.Gly180_Asn181insValLysTyr | p.G180_N181insVKY | Q92870 | protein_coding | TCGA-A7-A0CJ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD | ||
APBB2 | insertion | Frame_Shift_Ins | novel | c.1976_1977insTGAAGTAA | p.Phe660GlufsTer56 | p.F660Efs*56 | Q92870 | protein_coding | TCGA-A8-A09D-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR | ||
APBB2 | insertion | Nonsense_Mutation | novel | c.1975_1976insTTTTCACCAATTGACATACTACTGAT | p.Ser659PhefsTer5 | p.S659Ffs*5 | Q92870 | protein_coding | TCGA-A8-A09D-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR | ||
APBB2 | insertion | Nonsense_Mutation | novel | c.1935_1936insCAGTTATGATAAACAGATTACATCTCCAAAGGCCAGAACTC | p.Glu646GlnfsTer3 | p.E646Qfs*3 | Q92870 | protein_coding | TCGA-BH-A0H6-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
APBB2 | deletion | Frame_Shift_Del | novel | c.2233delN | p.Leu745SerfsTer5 | p.L745Sfs*5 | Q92870 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | ||
APBB2 | SNV | Missense_Mutation | c.1893N>C | p.Met631Ile | p.M631I | Q92870 | protein_coding | tolerated(0.07) | benign(0.007) | TCGA-C5-A1BM-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD | |
APBB2 | SNV | Missense_Mutation | c.106N>A | p.Pro36Thr | p.P36T | Q92870 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-FU-A23L-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |